Table of Contents

Fluvoxamine (Luvox)

Primer

Pharmacokinetics

Pharmacokinetics of Fluvoxamine

Fluvoxamine: Cytochrome P450 Metabolism

Substrate of (Metabolized by)
Induces
Inhibits* 1A2, 2C19, 3A4 (potent)

Pharmacodynamics

Mechanism of Action

Toxicity

Indications

Dosing

Dosing for Fluvoxamine

Starting 50 mg, often split into BID dosing
Titration
Maximum 300 mg
Taper

Formulations

Monitoring

Contraindications

Absolute

Relative

Drug-Drug Interactions

Side Effects

Adverse Events

Clinical Pearls

Special Populations

Geriatric

Pediatric

Obstetric and Fetal

Medically Ill

Resources